Suzhou, China

Zi Chen

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Inventor Zi Chen

Introduction

Zi Chen is a notable inventor based in Suzhou, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific cancer pathways. His work is characterized by a focus on innovative treatments for hematologic malignancies.

Latest Patents

Zi Chen holds a patent for N-(phenylsulfonyl)benzamides and related compounds as Bcl-2 inhibitors. This patent describes methods of treating hematologic malignancies in patients by administering a Bcl-2 inhibitor through a step-wise dosing regimen. His innovative approach aims to improve treatment outcomes for patients in need.

Career Highlights

Throughout his career, Zi Chen has worked with Ascentage Pharma (Suzhou) Co., Ltd. and Ascentage Pharma Group Corp Limited. His experience in these companies has allowed him to contribute to the advancement of cancer therapies and to collaborate with leading experts in the field.

Collaborations

Zi Chen has collaborated with notable colleagues such as Yifan Zhai and Dajun Yang. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in cancer treatment.

Conclusion

Zi Chen's contributions to the field of pharmaceuticals, particularly through his patent on Bcl-2 inhibitors, highlight his role as an influential inventor. His work continues to pave the way for advancements in cancer treatment, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…